Replies to post #204648 on Biotech Values

[haysaw]

ACOR: Still dropping. This is all I got, as to why:

$ACOR down bc last week’s court hearings on Ampyra patent challenge didn’t go well. Increased chance of generic launch in 2018.

— Adam Feuerstein ✡️ (@adamfeuerstein) September 26, 2016